ZIOPHARM Oncology, Inc. (ZIOP) Earning

NASDAQ Currency in USD Disclaimer

$0.87

north_east NA Past Year
Day's range
$0.86
Day's range
$0.97

ZIOPHARM Oncology, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/08/2021 Q3 2021 -$0.13 -$0.11 0.02 $398,000
08/13/2021 Q2 2021 -$0.12 -$0.11 0.01 $0
05/06/2021 Q1 2021 -$0.10 -$0.10 0 $0
03/01/2021 Q4 2020 -$0.11 $0
11/05/2020 Q3 2020 -$0.09 -$0.10 -0.01 $0
08/06/2020 Q2 2020 -$0.09 -$0.09 0 $0
05/07/2020 Q1 2020 -$0.08 -$0.09 -0.01 $0
03/02/2020 Q4 2019 -$0.08 -$0.09 -0.01 $0
11/07/2019 Q3 2019 -$0.09 -$0.43 -0.34 $0
08/08/2019 Q2 2019 -$0.08 -$0.09 -0.01 $0
05/08/2019 Q1 2019 -$0.08 -$0.08 -0 $0
03/05/2019 Q4 2018 -$0.11 -$0.08 0.03 $0
11/09/2018 Q3 2018 -$0.09 $0
08/08/2018 Q2 2018 -$0.09 $0
05/10/2018 Q1 2018 -$0.11 $146,000
03/01/2018 Q4 2017 -$0.09 $1.60 M
11/06/2017 Q3 2017 -$0.09 $1.60 M
07/31/2017 Q2 2017 -$0.09 $1.60 M
05/01/2017 Q1 2017 -$0.12 $1.60 M
02/16/2017 Q4 2016 -$0.09 $1.60 M
 

ZIOPHARM Oncology, Inc. Earnings: FAQ's

When is ZIOPHARM Oncology, Inc.'s earnings date?

ZIOPHARM Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 23rd, 2022 based off last year's report dates.

Did ZIOPHARM Oncology, Inc. beat their earnings estimates last quarter?

In the previous quarter, ZIOPHARM Oncology, Inc. (:ZIOP) reported $-0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.02.

How can I listen to ZIOPHARM Oncology, Inc.'s earnings conference call?

The conference call for ZIOPHARM Oncology, Inc.'s latest earnings report can be listened to online.

How can I read ZIOPHARM Oncology, Inc.'s conference call transcript?

The conference call transcript for ZIOPHARM Oncology, Inc.'s latest earnings report can be read online.

How much profit does ZIOPHARM Oncology, Inc. generate each year?

ZIOPHARM Oncology, Inc. (:ZIOP) has a recorded net income of $0. ZIOPHARM Oncology, Inc. has generated $-0.38 earnings per share over the last four quarters.

What is ZIOPHARM Oncology, Inc.'s price-to-earnings ratio?

ZIOPHARM Oncology, Inc. (:ZIOP) has a price-to-earnings ratio of -2.27 and price/earnings-to-growth ratio is -0.02.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED